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Genotoxic stresses stabilize the p53 tumor suppressor
protein which, in turn, transactivates target genes to
cause apoptosis. Although Noxa, a “BH3-only” member
of the Bcl-2 family, was shown to be a target of p53-
mediated transactivation and to function as a mediator
of p53-dependent apoptosis through mitochondrial dys-
function, the molecular mechanism by which Noxa
causes mitochondrial dysfunction is largely unknown.
Here we show that two domains (BH3 domain and mito-
chondrial targeting domain) in Noxa are essential for
the release of cytochrome c from mitochondria. Noxa-
induced cytochrome c release is inhibited by permeabil-
ity transition pore inhibitors such as CsA or MgCl2, and
Noxa induces an ultra-structural change of mitochon-
dria yielding “swollen” mitochondria that are unlike
changes induced by tBid. This indicates that Noxa may
activate the permeability transition-related pore to re-
lease cytochrome c from mitochondria into cytosol.
Moreover, Bak-oligomerization, which is an essential
event for tBid-induced cytochrome c release in the ex-
trinsic death signaling pathway, is not associated with
Noxa-induced cytochrome c release. This finding sug-
gests that the pathway of Noxa-induced mitochondrial
dysfunction is distinct from the one of tBid-induced mi-
tochondrial dysfunction. Thus, we propose that there
are at least two different pathways of mitochondrial
dysfunction; one mediated through Noxa in response to
genotoxic stresses and the other through tBid in re-
sponse to death ligands.
The p53 mutation is found in more than half of all human
cancer patients. Cancers with loss of p53 function are often
resistant to chemotherapeutic agents mainly because of the
absence of p53-dependent apoptosis (1–3). The p53-dependent
apoptosis largely depends on the capability of p53 to function as
a transcription factor, although recent reports show that the
transcription-independent function of p53 plays a role in this
process. There are many target genes (e.g. Apaf-1, DR5,
p53AIP, PUMA, and Noxa) transactivated by p53 that are
proposed to mediate p53-dependent apoptosis in various cancer
cells (4). A recent report shows a close correlation between p53
level and Noxa induction that could be a key determinant of
chemically induced hepatocellular carcinoma in mice, suggest-
ing that Noxa is a crucial mediator of p53-dependent apoptosis
in the liver (5). Noxa induced by p53 is up-regulated by x-ray
irradiation and is heavily dependent on p53 and its homologue
p73 (6). Noxa belongs to the “BH3-only” branch of the Bcl-2
protein family, although mouse Noxa has two BH3 domains,
whereas other BH3-only proteins have a single BH3 domain.
Like many Bcl-2 family proteins that translocate to mitochon-
dria and modulate mitochondrial function, Noxa translocates
to mitochondria and then leads to cytochrome c release and
caspase-9 activation (7). Most of the BH3-only proteins such as
Bid and Bim appear to induce efflux of mitochondrial death-
stimulating proteins through Bax or Bak homo-oligomerization
leading to the permeabilization of the mitochondrial outer
membrane (8, 9). However, the detailed molecular mechanism
by which Noxa induces mitochondrial dysfunction remains to
be solved. In these studies, we characterize Noxa-induced mi-
tochondrial dysfunction in order to provide insight into the
molecular mechanism by which p53 induces apoptosis. We
show that Noxa causes mitochondrial dysfunction by a distinct
pathway in mediating p53-dependent apoptosis, unlike mito-
chondrial dysfunction induced by tBid in response to FasL or
tumor necrosis factor-.
MATERIALS AND METHODS
Cell Culture and Mitochondrial Localization—HeLa cells were
seeded onto an 8-well Lab-Tek chamber slide glass (Nunc) and were
grown in Dulbecco’s modified Eagle’s medium supplemented with 10%
fetal bovine serum (Invitrogen). The indicated GFP1-Noxa plasmids
were transfected into HeLa cells using Effectene (Qiagen) according to
the manufacturer’s instructions and cultured for 2 additional days. In
some experiments, Mitotracker Red CMXROS (Molecular Probes Inc.)
was added to the medium at a final concentration of 200 nM, and cells
were incubated for a further 10 min. In these experiments, the dye was
visualized without a fixation step. After washing with PBS, fresh me-
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dium was added. Mitochondrial localization was analyzed with a laser
scanning confocal microscope (Leica Microsystems TCS NT).
Immunostaining of Cytochrome c—HeLa cells were rinsed with PBS
three times and fixed with ice-cold 2% buffered paraformaldehyde (pH
7.4) for 10 min. After washing with PBS and blocking with a buffer
containing 0.1% saponin and 0.05% BSA in PBS, pH 7.4, for 30 min, the
cells were incubated with anti-cytochrome c antibody (dilution 1:250,
BD Biosciences) for 1 h at 30 °C and then washed with the blocking
buffer. Tetramethylrhodamine-labeled anti-mouse IgG antibody (dilu-
tion 1:250, BD Biosciences) was added to the cells, and they were
incubated for 1 h more. After washing with PBS, cells were examined
with the laser scanning confocal microscope.
Apoptosis Assay—HeLa cells were cultured in 24-well plates and
transfected with the indicated plasmid constructs. Each well was har-
FIG. 1. Human Noxa induces cell death through mitochondrial dysfunction. A, GFP-human Noxa (1–54) (200 ng/well) and luciferase (100
ng/well) expression plasmids were transfected into HeLa cells in the presence of z-VAD-fmk (20 M) or a Bcl-xL (300 ng/well) expression plasmid.
Luciferase activity was measured to determine the rate of cell death. B, plasmids expressing GFP (200 ng/well) or GFP-Noxa (1–54) (200 ng/well)
were transfected into HeLa cells. After 2 days in culture, cytochrome c was immunostained and observed with a laser scanning confocal microscope.
C, alternatively, GFP in the cells was visualized in the presence of Mitotracker Red CMXROS (200 nM). Arrows indicate cytochrome c staining
(diffuse or obvious) in the cells where transfection has occurred.
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vested after 48 h of culture, and lysates were prepared using the
luciferase assay system (Promega). Luciferase activities were deter-
mined by using a Micro-Lumat Plus LB96V microplate luminometer
(Berthold Technologies) and were normalized against control -galac-
tosidase activities.
Purification of Recombinant Human Noxa—Recombinant human
Noxa protein was expressed in Escherichia coli BL21(DE3) cells trans-
formed with pET30()a-human Noxa (1–54). It was induced by the
addition of 0.8 mM isopropyl-1-thio--D-galactopyranoside for 3 hours.
Purification was carried out according to the company’s instructions
(Novagen).
Cytochrome c Release Assay and Assay of Endonuclease G Activity—
Isolated mitochondria treated with recombinant Noxa protein were
incubated at 30 °C for 1 h in buffer containing 250 mM sucrose, 10 mM
HEPES-NaOH, pH 7.5, 2 mM KH2PO4, 5 mM sodium succinate, and 25
M EGTA. After centrifugation at 10,000  g for 10 min, supernatants
were subjected to SDS-PAGE, and released cytochrome c was visualized
by Western blot analysis.
Analysis of Bak-oligomerization—Mitochondria were isolated from
either mouse or rat liver and treated with either tBid or Noxa before
incubation for 1 h at 30 °C. After centrifugation, mitochondrial pellets
were resuspended in buffer B containing 250 mM sucrose, 10 mM
HEPES-NaOH, pH 7.5, 2 mM KH2PO4, 5 mM sodium succinate, and 25
M EGTA. A cross-linking agent of bismaleimide hexane (10 M) or
alternatively, Me2SO as a control, was then added. After further incu-
bation for 30 min at room temperature with shaking, mitochondrial
pellets were harvested by centrifugation and then analyzed by Western
blot analyses using anti-Bak antibody.
Alignment of Expressed Sequence Tag Clones of Noxa Homologues—
Expressed sequence tag clones of cow, chicken, and pig Noxa were
identified by a Blast search at the NCBI web site using human Noxa/
APR as the reference. GenBank accession numbers of identified ex-
pressed sequence tag clones containing cow, chicken, and pig homo-
logues of Noxa are BF075905, AJ450393, and AF319660, respectively.
RESULTS
It has been reported that mouse Noxa has two BH3 domains
and induces apoptosis, whereas human Noxa has only one BH3
domain. First, to determine whether human Noxa is able to
induce cell death in HeLa cells, GFP-Noxa (1–54) was trans-
fected into HeLa cells. As shown in Fig. 1A, GFP-Noxa (1–54)
induced cell death, and Bcl-xL blocked Noxa-induced cell death.
In addition, the pan-caspase inhibitor z-VAD-fmk inhibited
Noxa-induced cell death, indicating that caspases play a crucial
role in Noxa-induced cell death. These results indicate that one
BH3 domain in human Noxa is sufficient to induce apoptosis.
To determine whether cytochrome c release accompanies hu-
man Noxa-induced cell death, GFP-Noxa (1–54) was trans-
fected into HeLa cells, and the cells were immunostained using
anti-cytochrome c antibody. HeLa cells transfected with human
Noxa showed diffuse cytochrome c distribution throughout the
cytosol, but control cells (transfected with GFP alone) main-
tained the typical mitochondrial distribution of cytochrome c
(Fig. 1B), indicating that cytochrome c release from mitochon-
dria is an event induced during human Noxa-mediated cell
death. To further confirm that human Noxa targets to mito-
chondria and causes mitochondrial dysfunction, we checked
whether GFP-Noxa (1–54) was present in mitochondria after
transfection. GFP-Noxa (1–54) showed a punctate distribution
typical of mitochondria (Fig. 1C, left panel, green color), and
mitochondrial localization of Noxa was confirmed by overlap-
ping staining (Fig. 1C, right panel, yellow color) with Mito-
tracker (Fig. 1C, middle panel, red color). This finding is in
agreement with a previous report showing the mitochondrial
FIG. 2. Noxa is able to release cytochrome c from isolated mitochondria. A, recombinant tBid (0.1 g ml1) or recombinant human Noxa
(1, 2.5, 5, 10, 25, and 50 g ml1) was incubated with isolated mitochondria at 30 °C for 1 h. After centrifugation, supernatants were subjected to
Western blot analysis with anti-cytochrome c antibody. B, isolated mitochondria were treated with tBid (0.1 g ml1) or Noxa (50 g ml1) in the
presence of Bcl-xLTM (30 g ml
1) and incubated at 30 °C for 1 h. Cytochrome c was visualized in the supernatants by Western blot analysis.
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localization of mouse Noxa when using an adenovirus express-
ing mouse Noxa and suggests that human Noxa is functionally
identical to mouse Noxa despite having a single BH3
domain (7).
Although the data indicated that human Noxa causes the
release of cytochrome c from mitochondria in HeLa cells, it was
not clear whether Noxa is able to directly trigger efflux of
death-stimulating proteins from the inter-membrane space of
mitochondria or whether another, non-mitochondrial, factor is
also necessary. To address this question, we adopted the in
vitro system of Noxa-induced mitochondrial dysfunction. In
this system, recombinant human Noxa protein was able to
induce cytochrome c release directly from isolated mitochon-
dria. Noxa-induced cytochrome c release was inhibited by Bcl-
xLTM (Fig. 2, A and B). These results strongly suggest that
the presence of human Noxa in mitochondria is enough to
induce mitochondrial dysfunction.
It has been shown that a death ligand-activated BH3-only
protein, tBid, targets to the mitochondria and that the DEF
helices of tBid play a crucial role in this localization. We hy-
pothesized that human Noxa may have a mitochondrial target-
ing domain (MTD), similar to tBid. To determine the MTD of
FIG. 3. C-terminal region of Noxa contains the mitochondrial targeting domain. A and B, schematic diagrams of plasmid constructs
expressing various regions of Noxa fused to GFP are presented. Plasmid constructs containing the indicated regions of Noxa fused to GFP were
transfected into HeLa cells and cultured for 2 days. Cells were visualized for co-localization of Mitotracker CMXROS (200 nM) and GFP using a
confocal microscope. C, sequence alignment of Noxa from human, mouse, cow, chicken, and pig. The BH3 domain and the MTD are indicated. D,
plasmids expressing the indicated regions of Noxa fused to GFP (200 ng/well) were transfected into HeLa cells with the reporter plasmid, luciferase
(100 ng/well), and further cultured for 2 days before measuring the luciferase activity.
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Noxa, various expression plasmids of Noxa fused to GFP were
transfected into HeLa cells (Fig. 3A). In Fig. 1 we showed that
Noxa (1–54) displays the punctate distribution that is typical of
a mitochondrial staining pattern, and mitochondrial distri-
bution of Noxa (1–54) was confirmed by overlapped staining
with Mitotracker. This same punctate distribution disappeared
in Noxa (1–30) and Noxa (1–40); however, Noxa (21–54)
and Noxa (31–54) maintained a similar pattern, indicating that
Noxa (31–54) contains the MTD. To define the MTD of Noxa,
Noxa (31–54) was dissected as shown in Fig. 3B. Noxa (31–40)
and Noxa (31–45) showed a dispersed cytoplasmic distribution,
whereas Noxa (41–54) and Noxa (41–50) displayed the punc-
tate pattern. These results demonstrate that human Noxa (41–
50) contains the entire MTD. This MTD seems to be conserved
between human, mouse, cow, pig, and chicken (Fig. 3C), sug-
gesting that the MTD of Noxa is functionally significant for
induction of cell death in p53-dependent apoptosis.
To verify whether human Noxa needs the MTD to kill cells,
plasmids containing various GFP-Noxa constructs and a re-
porter gene were co-transfected into HeLa cells. Noxa (1–54)
FIG. 4. Cytochrome c release in-
duced by Noxa needs BH3 and MTD
domains. Plasmids expressing the indi-
cated regions of Noxa fused to GFP (200
ng/well) were transfected into HeLa cells.
After 2 days in culture, cytochrome c was
stained with anti-cytochrome c antibody.
All data are representative of three sepa-
rate experiments. Arrows indicate cyto-
chrome c staining (diffuse or obvious) in
the cells where transfection has occurred.
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and Noxa (21–54), which have intact BH3 and MTD domains,
were able to induce cell death (Fig. 3D). We further confirmed
that the cell killing induced by Noxa (1–54) and Noxa (21–54)
was associated with an efflux of cytochrome c from mitochon-
dria (Fig. 4). Interestingly, Noxa (11–40) and Noxa (21–40),
which have the BH3 domain but not the MTD domain, failed to
induce cell death (Fig. 3D). In addition, Noxa (31–54) and Noxa
(41–54), which have the MTD domain but harbor a disrupted
BH3 domain or no BH3 domain, respectively, failed to induce
apoptosis, indicating that the MTD domain is necessary but not
enough to induce cell death (Fig. 3D). These results demon-
strate that the killing activity of the Noxa BH3 domain is
functional only when it targets to mitochondria, and this mi-
tochondria targeting is mediated by the MTD.
It is known that after engagement of death ligands to death
receptors, caspase-8-activated tBid binds to cardiolipin, which
exists exclusively in the mitochondrial membrane and is en-
riched at the inner membrane and the mitochondrial contact
sites. The interaction of tBid with cardiolipin is a critical step
for tBid targeting to mitochondria (10, 11). To understand the
molecular mechanism by which Noxa targets to mitochondria
in p53-dependent apoptosis, we examined whether Noxa also
targets to cardiolipin like tBid. It is unlikely that Noxa binds to
cardiolipin (data not shown), and it implies that p53-mediated
mitochondrial dysfunction through Noxa might be distinct
from mitochondria dysfunction triggered by death ligands that
is mediated through tBid. To examine whether Noxa triggers
an efflux of mitochondrial proteins in a manner distinct from
tBid, we examined the inhibitory activity of CsA in a cyto-
chrome c release assay. CsA showed no significant change in
the release of cytochrome c induced by tBid, consistent with a
previous report (12) (Fig. 5A). On the other hand, calcium,
which is a strong activator of the PT pore, was able to release
cytochrome c from isolated mitochondria and, as expected, was
inhibited by CsA. Surprisingly, CsA also blocked Noxa-induced
cytochrome c release. In addition, Mg2, another inhibitor of
the PT pore, was also able to inhibit Noxa-induced cytochrome
c release, indicating that Noxa in p53-dependent apoptosis is
likely to cause efflux of mitochondrial proteins through a PT-
related pore in a manner that is distinct from the tBid-induced
pathway activated by death ligands.
Bak-oligomerization is a key event of tBid-induced cyto-
FIG. 5. Differential mitochondrial dysfunction between tBid and Noxa. A, supernatants were analyzed by Western blot analysis using
anti-cytochrome c antibody. Isolated mitochondria were treated with tBid (0.1 g ml1), Noxa (50 g ml1), CaCl2 (50 M), or MgCl2 (4 mM) in the
presence or absence of CsA (50 M). Cytochrome c in the supernatant was analyzed by Western blot analysis. B, isolated mitochondria from either
mouse or rat livers were treated with either tBid (0.1 g ml1) or Noxa (50 g ml1) and then incubated for 1 h at 30 °C. After centrifugation,
mitochondrial pellets were resuspended, and either the cross-linking agent bismaleimide hexane (10 M) or Me2SO as a control buffer was added.
The supernatants were analyzed by Western blot analysis using anti-cytochrome c antibody. After further incubation with shaking for 30 min at
room temperature, mitochondrial pellets were harvested by centrifugation and then analyzed by Western blotting using anti-Bak antibody.
Equivalent protein loading was verified by Western blotting using anti-cytochrome c oxidase IV antibodies.
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chrome c release. In fact, tBid is unable to release cytochrome
c from Bak-deficient mitochondria (8, 9). A recent report
showed that unlike mouse liver, rat liver mitochondria display
little or no cytochrome c release in response to tBid because of
either insufficient or absent Bak in their mitochondria (13).
Therefore, we analyzed Bak-oligomerization using mouse and
rat liver mitochondria to determine whether Bak-oligomeriza-
tion is an important component of Noxa-induced cytochrome c
release. The cross-linker bismaleimide hexane or (as a control)
Me2SO has been used for Bak-oligomerization analyses. As
expected, tBid induced significant Bak-oligomerization from
mouse but not rat mitochondria. Noxa did not cause significant
Bak-oligomerization in either case, although it was able to
effect cytochrome c release (Fig. 5B). Furthermore, our results
confirmed that rat liver mitochondria only release a small
amount of cytochrome c in response to tBid (Fig. 5B). On the
other hand, Noxa was able to release a comparable amount of
cytochrome c from both rat and mouse mitochondria without
Bak-oligomerization. These results reveal that Bak-oligomer-
ization is not required for cytochrome c release in response to
Noxa. However, we do not rule out the possibility that Bax may
be involved in the Noxa-induced cytochrome c release because
Bax is able to compensate for Bak-deficiency.
Because CsA and Mg2 are blocking agents of the PT pore
and inhibit Noxa-induced cytochrome c release (Fig. 5A), we
assumed that Noxa is likely to activate the PT pore, resulting
in mitochondrial swelling. We next measured mitochondrial
swelling by light scatter after Noxa treatment; however, we
were unable to detect any significant high amplitude swelling
(data not shown). Recently, Scorrano et al. reported that tBid
causes cristae-remodeling of the mitochondrial structure, re-
sulting in the movement of cytochrome c stores (14). We hy-
pothesized that Noxa might also cause ultra-structural
changes in the mitochondria without high amplitude swelling,
and this structural change might be distinct from that induced
by tBid. To examine the hypothesis, morphological changes of
mitochondria treated with tBid, Noxa, or calcium were ob-
served using electron microscopy. As shown in Fig. 6A, freshly
isolated mitochondria showed an electron-dense matrix of the
isolated mitochondria, the typical “condensed state” described
by Hackenbrock (15). When tBid was used to treat the mito-
chondria, the electron-dense matrix was reorganized to have
mitochondrial features showing a “sausage-shaped” electron-
dense matrix (Fig. 6B), as described by Scorrano et al. (14).
Noxa-treated mitochondria, however, showed an expanded and
dilute matrix, and small matrical granules with tubular-
shaped cristae were widely dispersed (Fig. 6C). These morpho-
logical changes are characteristics of “swollen” mitochondria as
designated by Hackenbrock. It is likely that these morpholog-
ical changes take place without large amplitude mitochondrial
swelling because no significant changes in mitochondrial size
were observed. Thus, Noxa seems to cause changes in the
mitochondrial ultra-structure characteristic of swollen mito-
chondria without inducing large-amplitude swelling.
DISCUSSION
Mitochondrial dysfunction in response to FasL or tumor ne-
crosis factor- seems to be mediated through tBid activated by
caspase-8. This process requires either Bak- or Bax-oligomer-
ization to release cytochrome c and Smac without the opening
of PT pores (8, 9, 16). However, Bid may not be essential for
mitochondrial dysfunction in stress-activated death stimuli
such as -irradiation because Bid-deficient hepatocytes are
able to lose membrane potential of mitochondria in response to
these death stimuli (17). This indicates that there is an alter-
native pathway leading to mitochondrial dysfunction in stress-
activated death stimuli. Noxa may be the candidate protein for
induction of this alternative pathway because Noxa is transac-
tivated by p53 in response to genotoxic agents, and Noxa
causes mitochondrial dysfunction (7). Indeed, our present re-
sults show the differences of cytochrome c releases from mito-
chondria induced by tBid or Noxa. First, Noxa-induced cyto-
chrome c release is not dependent upon Bak-oligomerization,
whereas Bax- or Bak-oligomerization is requisite for tBid-in-
duced cytochrome c release. Although our data indicate that
Noxa-induced mitochondrial dysfunction is not associated with
Bak-oligomerization, we do not rule out the possibility of Bax
participation in this process. The fact that thymocytes isolated
from Bax/ and Bak/ mice are resistant to etoposide-in-
duced apoptosis suggests that Bax might be associated with
Noxa-induced mitochondrial dysfunction. However, this re-
mains to be answered. Second, PT-related components might,
at least in part, participate in the Noxa-induced permeabiliza-
tion of the mitochondrial outer membrane because the PT pore
inhibitors CsA and Mg2 are able to inhibit Noxa-induced
cytochrome c release. This is further supported by a Noxa-
induced swollen electron-dilute matrix, an indicator of the
opening of the PT pore. This supports the notion that stress-
activated p53 utilizes Noxa which leads to mitochondrial dys-
function in a distinct pathway through PT-related pore. To-
gether, it suggests that there are two different pathways in the
permeabilization of the mitochondrial outer membrane which
are activated by different death stimuli. This notion might
provide an explanation for enhanced apoptotic response of
some cancer cells to combinatory treatment of genotoxic agents
and death ligand. Bax-deficient colorectal cancer cells, for in-
stance, are resistant to TRAIL alone, mainly because of the
lack of cytochrome c release; however, these cells are sensitive
to TRAIL and the topoisomerase I inhibitor camptothecin. It is
possible that Bax-deficient cells have the defective pathway of
mitochondrial death signaling induced by tBid; however, the
camptothecin might restore the mitochondrial death signaling
through Noxa-mediated pathway.
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